Overview

iKanEat: A Randomized-controlled, Multi-center Trial of Megestrol for Chronic Oral Food Refusal in Children

Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
0
Participant gender:
All
Summary
This is a multi-center, randomized, placebo-controlled, double-blind clinical trial. The primary focus of the study is the evaluation of the effectiveness of treatment with megestrol as part of a 24 week behavioral feeding protocol in transitioning from tube to oral feedings in a pediatric population. Approximately 60 pediatric subjects matching the criteria for eligibility will be enrolled in the study and randomized to receive either megestrol (n=30) or placebo (n=30).
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University of Kansas Medical Center
Treatments:
Megestrol
Megestrol Acetate
Criteria
Inclusion Criteria:

1. Males and females aged 9 months to 9y0m at the time of consent.

2. Able to obtain parental or legal guardian written informed consent from subjects as
applicable by local laws and regulations.

3. Subjects must have a G or G/J tube.

4. Subjects must receive over 80% of their total daily calorie needs from a tube in order
to be classified as tube dependent.

5. Subjects must have a ≥ 3 month history of feeding problems as identified by a
diagnosis from a multidisciplinary feeding team, and must have permission from the
physician on the team to ensure that they are medically stable enough to participate
in a weaning study.

6. Subjects must possess the oral motor skills necessary for eating. Subjects must
possess behavioral skills necessary for mealtimes.

Exclusion Criteria:

1. Children receiving oral or inhaled steroids.

2. Parent has a known developmental delay or cognitive impairment that may make
participation in the study difficult (children with these issues will not be
excluded).

3. Children receiving intensive (defined as more than one session per month) behavioral
feeding therapy with a licensed psychologist (previous behavioral feeding therapy is
not an exclusion criterion; neither is current oral-motor, sensory, or speech
therapy).

4. Children of non-English speaking parents.